Royal Jelly Components Encapsulation in a Controlled Release System-Skin Functionality, and Biochemical Activity for...

Area of Science:

• Bee products research
• Cosmeceutical science
• Biomaterial engineering

Background:

• Royal jelly, a bee secretion, possesses numerous beneficial properties including antimicrobial, anti-inflammatory, antioxidant, and anti-aging effects.
• Key bioactive compounds in royal jelly include royalactin and 10-hydroxy-2-decenoic acid (10-HDA), alongside polyphenols with antioxidant and photoprotective skin activity.
• Challenges exist in royal jelly extraction and application due to the physicochemical instability of its components, leading to degradation and color changes at higher temperatures.

Purpose of the Study:

• To develop a new encapsulation and delivery system for royal jelly.
• To enhance the stability of royal jelly's sensitive components, especially 10-HDA.
• To achieve controlled release of royal jelly ingredients for improved bioactivity in cosmeceutical applications.

Main Methods:

• Development of a novel delivery system using liposomes and cyclodextrins.
• Incorporation of royal jelly into the liposome-cyclodextrin matrix.
• Evaluation of the system's ability to stabilize 10-HDA and enable controlled release.

Main Results:

• A new liposome-cyclodextrin encapsulation system for royal jelly was successfully developed.
• The system addresses the stability issues of royal jelly's sensitive components, particularly 10-HDA.
• The delivery system facilitates controlled release of royal jelly ingredients, enhancing potential bioactivity.

Conclusions:

• The developed liposome-cyclodextrin system offers a promising solution for stabilizing royal jelly and its bioactive compounds.
• This innovation can overcome the limitations of traditional royal jelly applications in cosmetics.
• Enhanced stability and controlled release pave the way for more effective cosmeceutical products utilizing royal jelly.